Avadel Pharmaceuticals Market Cap

Avadel Pharmaceuticals has a market cap or net worth of $831.01 million as of April 25, 2025. Its market cap has decreased by -46.44% in one year.

Market Cap

831.01M

Enterprise Value

796.08M

1-Year Change

-46.44%

Ranking

#2495

Market Cap Chart

Since December 31, 2002, Avadel Pharmaceuticals's market cap has increased from $70.50M to $831.01M, an increase of 1,078.74%. That is a compound annual growth rate of 11.68%.

Market Cap History

Date	Market Cap	% Change
Apr 23, 2025	803.00M	-20.71%
Dec 31, 2024	1.01B	-20.13%
Dec 29, 2023	1.27B	186.71%
Dec 30, 2022	442.30M	-6.63%
Dec 31, 2021	473.70M	21.68%
Dec 31, 2020	389.30M	37.71%
Dec 31, 2019	282.70M	196.02%
Dec 31, 2018	95.50M	-70.71%
Dec 29, 2017	326.10M	-23.90%
Dec 30, 2016	428.50M	-12.68%
Dec 31, 2015	490.70M	11.85%
Dec 31, 2014	438.70M	118.37%
Dec 31, 2013	200.90M	165.74%
Dec 31, 2012	75.60M	-41.12%
Dec 30, 2011	128.40M	-22.88%
Dec 31, 2010	166.50M	-7.04%
Dec 31, 2009	179.10M	89.93%
Dec 31, 2008	94.30M	-60.61%
Dec 31, 2007	239.40M	-66.28%
Dec 29, 2006	710.00M	72.88%
Dec 30, 2005	410.70M	-1.49%
Dec 31, 2004	416.90M	-3.92%
Dec 31, 2003	433.90M	515.46%
Dec 31, 2002	70.50M	-

View and export this data all the way back to 2002. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	734.57B
UnitedHealth Group	387.15B
Johnson & Johnson	378.15B
AbbVie	301.01B
Novo Nordisk	284.50B
Abbott Laboratories	225.27B
Novartis AG	209.93B
AstraZeneca	208.11B

Market Cap Rankings